Actively Recruiting
Effects of Early Cardiopulmonary Rehabilitation in Patients With Acute Decompensated Heart Failure
Led by Izmir Bakircay University · Updated on 2025-12-04
40
Participants Needed
1
Research Sites
3 weeks
Total Duration
On this page
Sponsors
I
Izmir Bakircay University
Lead Sponsor
I
Istanbul University - Cerrahpasa
Collaborating Sponsor
AI-Summary
What this Trial Is About
Acute decompensated heart failure (ADHF) is a severe condition characterized by rapid deterioration of cardiac function, leading to impaired oxygen delivery and multi-organ dysfunction. ADHF often results in reduced physical and respiratory capacity, greater dependence on oxygen support, difficulty performing daily activities, and prolonged hospital stays. In recent years, early exercise-based cardiopulmonary rehabilitation (CPR) has been introduced as part of heart failure management. Evidence suggests that early CPR improves overall health and cardiac function in heart failure patients. However, data regarding its effects in ADHF remain limited. While some studies indicate that early CPR enhances physical function, its impact on respiratory parameters and clinical outcomes is less well established. Cardiopulmonary rehabilitation is a multidisciplinary program designed to promote physical, psychological, and social recovery in patients with cardiovascular and pulmonary diseases. It includes exercise training, education, psychosocial support, and behavioral strategies. Early CPR specifically aims to improve cardiovascular and respiratory functions in heart failure patients. Initiating CPR in the early phase of ADHF may accelerate recovery, strengthen cardiopulmonary function, shorten hospitalization, and improve quality of life. This study aims to evaluate the effects of early CPR on functional capacity, hemodynamic parameters, and respiratory parameters in patients with ADHF.
CONDITIONS
Official Title
Effects of Early Cardiopulmonary Rehabilitation in Patients With Acute Decompensated Heart Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients hospitalized with a diagnosis of acute decompensated heart failure
- Being clinically stable
You will not qualify if you...
- Diagnosed pulmonary, neurological, renal, liver, gastrointestinal, orthopedic or oncological diseases
- Having cardiomyopathy or congestive pericarditis
- Recent heart surgery in the past 6 months
- New or suspected thromboembolic event
- Presence of open wounds, ulcerations or major skin diseases in the lower legs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istanbul University- Cerrahpasa, Cardiology Institute
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
K
Kiymet Muammer, PT, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here